Metabolic syndrome and bladder cancer
WebThe study found that bladder cancer recurrence was significantly greater in obese patients (hazard ratio [HR] 1.76, 95% CI 1.36–2.28), but obesity was not significantly associated with bladder cancer overall survival (HR 1.21, 95% CI 0.97–1.52). One of the problems in evaluating outcomes in patients with non-muscle invasive bladder cancer ... WebSarcopenia, which represents the degenerative and systemic loss of skeletal muscle mass, is a multifactorial syndrome caused by various clinical conditions. Sarcopenia reflects …
Metabolic syndrome and bladder cancer
Did you know?
WebKeywords: metabolic syndrome, bladder cancer, diabetes, excessive body weight, susceptibility, prognosis, meta-analysis, cumulative meta-analysis. Introduction. … Web15 apr. 2011 · There are little data on the putative association between factors in the metabolic syndrome (MetS) and risk of bladder cancer. In the Metabolic Syndrome and Cancer project (Me-Can), measurements of height, weight, blood pressure and circulating levels of glucose, cholesterol, and triglycerides had b …
Web5 apr. 2024 · Results The search identified 73 meta-analyses and 83 health outcomes from 8601 unique articles, including 74 unique outcomes in meta-analyses of observational studies and nine unique outcomes in meta-analyses of randomised controlled trials. Significant harmful associations between dietary sugar consumption and 18 … Web3 okt. 2024 · Metabolic syndrome (MetS) is a group of metabolic abnormalities including central obesity, hypertension, dyslipidemia, insulin resistance, and subsequent diabetes ( …
Web16 okt. 2015 · The Metabolic syndrome (MetS) is an emerging condition worldwide, consistently associated with an increased risk of several cancers. Some information … Web11 apr. 2024 · ObjectivePancreatic cancer is a globally frequent cause of death, which can be caused by many factors. This meta-analysis was performed to assess the correlation …
Web1 mrt. 2024 · Despite the association between the metabolic syndrome and bladder cancer, the association between the metabolic syndrome and bacillus Calmette-Guérin failure is unknown. In this study we characterize disease recurrence following bacillus Calmette-Guérin in patients with and without metabolic syndrome. Methods:
Web10 jan. 2024 · Background The incidence of hepatobiliary cancer is steadily increasing. It is unclear if this rise is related to increasing trends in obesity, metabolic syndrome, and lifestyle changes. Methods A case-control study was performed using the Health Improvement Network (THIN) database. Cases with a diagnosis of liver, bile duct, and … dr nirbhay shrivastava bhopalWebIntroduction: Intravesical bacillus Calmette-Guérin (BCG) therapy is the gold standard adjuvant treatment for patients with high-grade non-muscle-invasive bladder cancer … rapaponeWeb16 okt. 2015 · Background: The Metabolic syndrome (MetS) is an emerging condition worldwide, consistently associated with an increased risk of several cancers. … rapa portugaldr niranjan sritharanWeb23 jun. 2024 · Metabolic syndrome (MS), which is characterised by obesity, insulin resistance ± glucose intolerance, dyslipidaemia, hypertension, pro-inflammatory state … dr nirankariWeb15 apr. 2011 · In the Metabolic Syndrome and Cancer project (Me-Can), measurements of height, weight, blood pressure and circulating levels of glucose, cholesterol, … dr nirasha chiranjanWebBackground: The incidence of hepatobiliary cancer is steadily increasing. It is unclear if this rise is related to increasing trends in obesity, metabolic syndrome, and lifestyle changes. Methods: A case-control study was performed using the Health Improvement Network (THIN) database. Cases with a diagnosis of liver, bile duct, and gallbladder cancers … dr niranjan singh st louis